Tectonic Therapeutic, Inc. (TECX)
30.63
-0.59
(-1.89%)
USD |
NASDAQ |
Sep 02, 10:20
Tectonic Therapeutic Net Income (Quarterly) : -22.28M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.28M |
| March 31, 2026 | -25.24M |
| December 31, 2025 | -19.23M |
| September 30, 2025 | -19.04M |
| June 30, 2025 | -19.98M |
| March 31, 2025 | -15.91M |
| December 31, 2024 | -12.37M |
| September 30, 2024 | -17.72M |
| June 30, 2024 | -12.67M |
| March 31, 2024 | -15.22M |
| December 31, 2023 | -7.869M |
| September 30, 2023 | -10.05M |
| June 30, 2023 | -10.46M |
| March 31, 2023 | -24.96M |
| December 31, 2022 | -25.03M |
| September 30, 2022 | -22.97M |
| June 30, 2022 | -28.05M |
| March 31, 2022 | -29.83M |
| December 31, 2021 | -28.23M |
| Date | Value |
|---|---|
| September 30, 2021 | -32.61M |
| June 30, 2021 | -31.39M |
| March 31, 2021 | -26.90M |
| December 31, 2020 | -28.13M |
| September 30, 2020 | -36.78M |
| June 30, 2020 | -28.83M |
| March 31, 2020 | -25.97M |
| December 31, 2019 | -22.66M |
| September 30, 2019 | -17.14M |
| June 30, 2019 | -16.06M |
| March 31, 2019 | -17.10M |
| December 31, 2018 | -16.02M |
| September 30, 2018 | -11.59M |
| June 30, 2018 | -10.51M |
| March 31, 2018 | -8.242M |
| December 31, 2017 | -7.596M |
| September 30, 2017 | -6.441M |
| June 30, 2017 | -2.534M |
| March 31, 2017 | -2.077M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 22.28M |
| EPS Diluted (Quarterly) | -1.175 |
| Enterprise Value | 377.85M |
| Earnings Yield | -14.90% |
| Normalized Earnings Yield | -14.90 |